CATIONIC POLYMERIC NANOCARRIERS INHIBIT CHEMOTHERAPY-INDUCED CANCER METASTASIS AND COGNITIVE IMPAIRMENT
#902Compositions of Azadirachta Indica and Methods of Treating Cancer
#903ANTIVIRAL 1,3-DI-OXO-INDENE COMPOUNDS
#904Liquid Tasimelteon Formulations and Methods of Use Thereof
#905THERAPEUTIC COMPOSITION DELIVERY DEVICE
#906CANNABIDIOL COMPOSITIONS HAVING MODIFIED CANNABINOID PROFILES
#907CDC7 Inhibitor Combinational Therapy
#908LASOFOXIFENE TREATMENT OF BREAST CANCER
#909METHODS OF TREATING CONDITIONS RELATED TO THE S1P1 RECEPTOR
#910TREATMENT OF PRIMARY CTLA-4 CHECKPOINT RELATED IMMUNODEFICIENCIES
#911COMPOSITIONS AND METHODS FOR IMPROVING BONE HEALTH USING SELF-EMULSIFYING FORMULATIONS OF DIINDOLYLMETHANE
#912COMPOUNDS USEFUL AS KINASE INHIBITORS
#913METHODS OF TREATING GUT MOTILITY DISORDERS
#914METHODS OF TREATING, AMELIORATING, AND/OR PREVENTING BACTERIAL INFECTION, OR METHODS OF REDUCING ADVERSE EFFECTS CAUSED BY BACTERIA
#915 ✅ Patent 12,280,040 granted on 2025-04-22Compositions and methods of a dihydroisoxazole compound that reduces ectoparasite infestations on fish
#916SMALL MOLECULE PEPTIDOMIMETIC FOR THE TREATMENT OF TAUOPATHIES
#917Methods for Preventing Ectopic Brain Mineralization in Alzheimer's Disease and Dementias
#918COMBINATION THERAPY FOR THE TREATMENT OF MASTOCYTOSIS
#919Methods of Treating Cancer With a B-RAF Inhibitor
#920METHODS OF REDUCING ITCH USING TOPICAL ROFLUMILAST COMPOSITIONS
#921METHODS OF REDUCING ITCH USING TOPICAL ROFLUMILAST COMPOSITIONS
#922eIF4G1-eIF1 INHIBITORS AND USE THEREOF
#923PHARMACEUTICAL COMPOSITIONS
#924Dosage Regimen
#925DOSING REGIMEN OF HIV CAPSID INHIBITOR
#926METHOD OF TREATING CANCER
#9271-Deoxynojirimycin To Mitigate Hepatic Ischemia- Reperfusion
#928DRUG FOR TREATING AFTEREFFECTS OF NOVEL CORONAVIRUS INFECTION
#929Methods of Treating Cancer
#930METHOD OF TREATMENT WITH MILSAPERIDONE
#931TREATMENT OF CARDIOPULMONARY DISORDERS
#932DERIVATIVES OF TURBINMICIN AS ANTIFUNGAL AGENTS
#933BUPROPION AS A MODULATOR OF DRUG ACTIVITY
#934LEVOCETIRIZINE AND MONTELUKAST IN THE TREATMENT OF CORONAVIRUS DISEASE AND SYMPTOMS THEREOF
#935PHARMACEUTICAL COMPOSITION OR DRUG KIT FOR ALLEVIATING OR TREATING FIBROTIC DISEASES, AND USE THEREOF
#936BTK INHIBITORS
#937Methods of Treating Cancers, Immune and Autoimmune Diseases, and Inflammatory Diseases Based on BTK Occupancy and BTK Resynthesis Rate
#938METHODS OF TREATING DISORDERS ASSOCIATED WITH CASTOR
#939WOUND TREATMENTS AND COMPOUNDS
#940USE OF COMPLEMENT FACTOR D INHIBITOR FOR TREATMENT OF LUPUS NEPHRITIS AND IMMUNOGLOBULIN A NEPHROPATHY
#941USE OF SHP2 INHIBITORS FOR THE TREATMENT OF INSULIN RESISTANCE
#942COMBINATIONS FOR THE TREATMENT OF CANCER
#943Ribociclib Tablet
#944SHP2 INHIBITOR COMPOSITIONS AND METHODS FOR TREATING CANCER
#945COMBINATION THERAPY COMPRISING A MAT2A INHIBITOR AND A TAXANE
#946Phosphodiesterase-5 Inhibitor Combinations, Methods of Making, and Methods of Use Thereof
#947STABLE FORMULATIONS OF SHR0302
#948USES
#949ANTIVIRAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME
#950TLR7/8-ANTAGONIST FOR TREATING SJÖGREN'S SYNDROME OR MIXED CONNECTIVE TISSUE DISEASE
#951COMBINATION TREATMENT OF CANCERS
#952PI3K-ALPHA INHIBITORS AND METHODS OF USE THEREOF
#953Methods for Treating Neurodegenerative Disorders
#954COMBINATION OF A CELL THERAPY AND A GAMMA SECRETASE INHIBITOR
#955CXCR7 INHIBITORS FOR THE TREATMENT OF CANCER
#956ANTIPSYCHOTIC AND USE THEREOF
#957METHODS AND COMPOSITIONS FOR TREATMENT OF PERIPHERAL NEUROPATHIES
#958CHLOROPHYLL COMPOSITION
#959EPA-EE LIPID NANOCOMPOSITE, FORMULATION THEREOF, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF
#960J-SERIES PROSTAGLANDIN-ETHANOLAMIDES AS NOVEL THERAPEUTICS FOR SKIN AND/OR ORAL DISORDERS
#961COMPOSITIONS AND METHODS FOR MUSCLE REGENERATION USING PROSTAGLANDIN E2
#962INJECTABLE COMPOSITION COMPRISING CYTOLYTIC COMPOUND IN GEL, GEL-FORMING SOLUTION OR GEL-FORMING SUSPENSION FOR REDUCTION OF FAT
#963BUDESONIDE 21-PHOSPHATE SODIUM SALT FOR USE AS ANTI-INFLAMMATORY OR ANTIASTHMATIC AGENT
#964MESALAMINE PHARMACEUTICAL FORMULATIONS AND METHODS OF USE THEREOF
#965SUSTAINED RELEASE COMPOSITION COMPRISING A HYDROXYALKYL METHYLCELLULOSE
#966A METHOD OF TREATING DEPRESSION BY IMMUNE MODULATION
#967METHOD FOR PRODUCING A CBD COMPRISING LIQUID OR SOLID AND USE THEREOF
#968Polycannabinoid Compositions and Uses Thereof
#969Compositions and Methods for Inhibiting and Treating Coronavirus Infections
#970APPLICATION OF MILTEFOSINE IN PROMOTING BONE FORMATION AND PREVENTING-TREATING OSTEOPOROSIS
#971PRODRUGS OF ALOX-15 INHIBITORS AND METHODS OF USING THE SAME
#972T CELL RECEPTORS FOR IMMUNOTHERAPY
#973LYSOPHOSPHATIDYLCHOLINE COMPOSITIONS
#974METHODS, COMPOSITIONS AND USES RELATED TO THE TREATMENT AND PREVENTION OF LEIGH’S SYNDROME
#975COMPOSITION FOR PREVENTION, AMELIORATION OR TREATMENT OF INFLAMMATORY BOWEL DISEASE COMPRISING GALACTO-OLIGOSACCHARIDE
#976BIOACTIVES AND THEIR USES
#977Compositions and Methods for Treating Bleeding and Bleeding Disorders
#978BACTERIAL DNA GYRASE INHIBITORS AND METHODS OF USE THEREOF
#9795-FU AND RNAOG COMBINED IMMUNOCHEMOTHERAPY FOR PANCREATIC CANCER TREATMENT
#980METHOD OF TREATING LONG-COVID INDUCED NEUROLOGIC DISEASES
#981EXON SKIPPING OLIGOMERS AND OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY
#982Method for Prophylaxis and Attenuation of COVID19 and other Inflammatory Microbial Acute Respiratory Disease Syndromes through Modulation of Innate and Adaptive Immunity with Poly ICLC
#983CARD9 ATTENUATES AB PATHOLOGY AND MODIFIES MICROGLIAL RESPONSES IN AN ALZHEIMER’S DISEASE
#984COMPOSITIONS INCORPORATING SULFATED POLYSACCHARIDES FOR INHIBITING SARS-COV-2
#985COMPOSITIONS FOR DELIVERING NITRIC OXIDE AND FLUORIDE AND METHODS FOR MAKING AND USING THE SAME
#986BIOMATERIAL COMPRISING POLY(ITACONATE-CO-DODECANEDIOL)
#987SYSTEM AND METHOD OF USE FOR HALOTHERAPY SESSIONS
#988METHODS FOR TREATING NONTUBERCULOUS MYCOBACTERIA DISEASES
#989CLAY MINERAL BIOMATERIAL, AND PREPARATION METHOD AND USE THEREOF
#990METHOD OF PRODUCING A POPULATION OF IMMUNE CELLS FROM PLURIPOTENT STEM CELLS
#991DNVSIG3 AND DNVSIG8 RECEPTORS AND METHODS OF USING THE SAME
#992METHODS AND COMPOSITIONS FOR USING ACTIVATED LYMPHOCYTES IN THE TREATMENT OF DISEASE
#993MULTISTEP PROCESS FOR CULTURING TUMOR-INFILTRATING LYMPHOCYTES FOR THERAPEUTIC USE
#994GENETICALLY ENGINEERED CELLS HAVING ANTI-CD133 / ANTI-EGFR CHIMERIC ANTIGEN RECEPTORS, AND USES THEREOF
#995UNIVERSAL TCR VARIANTS FOR ALLOGENEIC IMMUNOTHERAPY
#996TREATMENT OF AUTOIMMUNE DISEASES WITH ENGINEERED IMMUNE CELLS
#997MODIFIED REGULATORY T CELLS AND METHODS OF USING THE SAME
#998METHODS FOR PRODUCTION OF PLATELETS FROM PLURIPOTENT STEM CELLS AND COMPOSITIONS THEREOF
#999PLATELET-DERIVED MITOCHONDRIA-CONTAINING EXTRACELLULAR VESICLES FOR USE IN THE TREATMENT OF OCULAR DISORDERS
#1000METHODS OF TREATING OR PREVENTING PREMATURE OVARIAN INSUFFICIENCY, POLYCYSTIC OVARY SYNDROME, OR INFERTILITY USING EXOSOMES OR MESENCHYMAL STEM CELLS
#1001METHOD OF TREATING PROGRESSIVE HEART FAILURE IN SUBJECTS AT HIGH RISK OF POOR OUTCOMES
#1002MESENCHYMAL STROMAL CELLS AND USES RELATED THERETO
#1003MESENCHYMAL STEM CELL WOUND REPAIR DOMINANT FUNCTIONAL CLUSTER, IDENTIFICATION THEREOF, AND APPLICATION
#1004Treatment of Mitochondrial Disease with Autologous Expanded Mesenchymal Stem Cell Therapy
#1005METHOD FOR PRODUCING HYDROGEL MICROBEADS CAPABLE OF MAGNETIC ACTUATION FOR DELIVERY OF THERAPEUTIC SUBSTANCE, HYDROGEL MICROBEADS PRODUCED THEREBY, AND PHARMACEUTICAL COMPOSITION FOR TREATING MUSCULOSKELETAL DISORDERS COMPRISING SAME
#1006THERAPEUTIC USE OF FIBROBLASTS TO STIMULATE THE IMMUNE SYSTEM
#1007THERAPEUTIC USE OF CANCER-ASSOCIATED FIBROBLAST-ENCAPSULATED PANCREATIC BETA CELLS FOR TREATING DIABETES
#1008MODULATING INFLAMMATION ASSOCIATED WITH FOREIGN BODY RESPONSE
#1009AIRWAY BASAL CELL ENGRAFTMENT METHODS
#1010SYSTEMS AND METHODS FOR THROMBOSIS PREVENTION
#1011METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY SKIN DISEASE WITH RECOMBINANT MICROORGANISMS
#1012MICROBIOTA RESTORATION THERAPY (MRT), COMPOSITION AND METHODS OF MANUFACTURE
#1013COMPOSITIONS AND METHODS FOR C. DIFFICILE TREATMENT
#1014AMMONIA OXIDIZING MICROORGANISMS FOR THE REGULATION OF BLOOD PRESSURE
#1015COMPOSITIONS CONTAINING BACILLAENE PRODUCING BACTERIA OR PREPARATIONS THEREOF
#1016STRAIN OF PEDIOCOCCUS ACIDILACTICI WITH FUNCTION OF TREATING ULCERATIVE COLITIS AND APPLICATION THEREOF
#1017NOVEL LACTOBACILLUS PARACASEI ATG-E1 STRAIN OR COMPOSITION COMPRISING SAME FOR PREVENTING OR TREATING RESPIRATORY DISEASE
#1018COMPOSITIONS FOR TREATMENT OF A FATTY LIVER OR FIBROTIC LIVER DISEASE
#1019FASTING-MIMICKING DIET (FMD) BUT NOT WATER-ONLY FASTING PROMOTES REVERSAL OF INFLAMMATION AND IBD PATHOLOGY
#1020BACTERIOPHAGE HAVING BACTERIOLYSIS ACTIVITY ON XANTHOMONAS SPP.
#1021COMPOSITIONS AND METHODS FOR PROMOTING DEVELOPMENT OF INFANT
#1022COMPOSITION, AND EXTRACT OF CHLAMYDOMONAS REINHARDTII
#1023T CELL DIFFERENTIATION-REGULATING AGENT AND COMPOSITION
#1024FEED ADDITIVE COMPOSITIONS AND METHODS OF USE
#1025AN ANTI-CANCER HERBAL COMPOSITION
#1026COMPOSITIONS AND METHODS FOR IMPROVING LUNG FUNCTION
#1027MULTIVITAMIN FOR AUXILIARY REGULATION OF BLOOD PRESSURE AND PREPARATION METHOD AND APPLICATION THEREOF
#1028COMPOSITION FOR IMPROVING SLEEP
#1029FORMULATIONS FOR TREATING OBESITY AND DIABETES AND FOR PROVIDING OTHER HEALTH RELATED BENEFITS
#1030COMBINATION FOR USE FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA, HYPERLIPIDEMIA, CARDIOVASCULAR DISEASE AND METABOLIC SYNDROME
#1031SINGLE PROCESS FOR SEQUENTIAL EXTRACTION OF PRODUCTS FROM GREEN TEA LEAVES
#1032PRODUCTION OF PROTECTIVE LOZENGE/CHEWABLE TABLET AGAINST SARS-COV-2 VIRUS
#1033METHODS AND COMPOSITIONS FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION
#1034ANGIOTENSIN COMPOSITIONS AND METHODS RELATED THERETO
#1035 ✅ Patent 12,343,372 granted on 2025-07-01DESMOPRESSIN ORAL COMPOSITIONS
#1036MODULATORS OF COMPLEMENT ACTIVITY
#1037CYCLOSPORINE FORMULATIONS FOR USE IN THE TREATMENT OF BRONCHIOLITIS OBLITERANS SYNDROME (BOS)
#1038NEW PEPTIDE AND USES THEREOF
#1039NUTRITIONAL POLYPEPTIDE HAVING BRANCHED-STRUCTURE WITH EFFICIENT BROAD-SPECTRUM ANTIBACTERIAL AND ANTIFUNGAL FUNCTIONS
#1040METHODS AND COMPOSITIONS FOR TREATING HERPES SIMPLEX VIRUS
#1041ALLEVIATING DRUG NEPHROTOXICITY
#1042USE OF PBX1 IN PROMOTING HAIR GROWTH
#1043Method to Treat Cancer with Engineered T-Cells
#1044Methods of Treating Crohn's Disease with Anti-IL23 Specific Antibody
#1045THERAPEUTIC COMPOSITIONS AND METHODS OF USE THEREOF
#1046LYMPHANGIOGENESIS-PROMOTING AGENTS
#1047TREATMENT OF INTERVERTEBRAL DISC DEGENERATION
#1048H3.3 CTL PEPTIDES AND USES THEREOF
#1049METHODS OF INHIBITING CEREBRAL INFLAMMATION
#1050COMPOSITIONS IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION COMPRISING AMYLIN, AN AMYLIN AGONIST RECEPTOR OR AN AMYLIN ANALOGUE AND A CO-POLYAMINO ACID
#1051CONTROLLED-RELEASE CNP AGONISTS WITH LOW INITIAL NPR-B ACTIVITY
#1052METHOD OF IMPROVING THE VIABILITY OF A DENTAL IMPLANT
#1053EXPRESSION VECTOR FOR CHOLESTEROL 24-HYDROLASE IN THERAPY OF POLYGLUTAMINE REPEAT SPINOCEREBELLAR ATAXIAS
#1054FOOD COMPOSITION FOR IMPROVING BEHAVIORAL AND MOTOR FUNCTION CONTAINING ALDEHYDE DEHYDROGENASE FOR REDUCING ALDEHYDES PRODUCED BY OXIDATION OF AMINE
#1055FUNCTIONALIZED BIOCATALYTICAL COMPOSITIONS
#1056E. COLI EXPRESSED RECOMBINANT HUMAN MICROPLASMIN, A PRODUCTION METHOD THEREOF, A PHARMACEUTICAL COMPOSITION AND A KIT COMPRISING THEREOF, A METHOD AND AN APPLICATION OF TREATING THROMBOEMBOLISM RELATED DISEASES BY USING THEREOF
#1057Radiohalogenated Agents for in Situ Immune Modulated Cancer Vaccination
#1058METHODS OF TREATING CANCER USING HETEROARYL-BIPHENYL AMIDE DERIVATIVES
#1059OPTIMIZED MULTIDIMENSIONAL BIOLOGICAL ACTIVITY OF POLY-ICLC WITH CONTROLLED COMPONENT SIZE AND FORMULATION
#1060NEXT GENERATION MRNA VACCINES
#1061INFLUENZA VIRUS MUTANTS AND USES THEREFOR
#1062MODIFIED INFLUENZA B HEMAGGLUTININ POLYPEPTIDES AND NUCLEIC ACIDS AND USES THEREOF
#1063RESPIRATORY SYNCYTIAL VIRUS F PROTEINS AND NANOSTRUCTURES AND USES THEREOF
#1064HENIPAVIRUS VACCINE
#1065SARS COV-2 VACCINE, ASSOCIATED POLYNUCLEOTIDES, AND METHODS OF USE
#1066CORONAVIRUS VACCINE COMPOSITIONS AND USES THEREOF
#1067BOOSTING SARS-COV-2 IMMUNITY WITH A LENTIVIRAL-BASED NASAL VACCINE
#1068NUCLEIC ACID VACCINE AGAINST THE SARS-COV-2 CORONAVIRUS
#1069NUCLEIC ACID VACCINE AGAINST THE SARS-COV-2 CORONAVIRUS
#1070POLYMER ADJUVANT
#1071COMBINATION THERAPY WITH AN ANTI-CD19 ANTIBODY AND PARSACLISIB
#1072Subcutaneous anti-HER2 Antibody Formulations and Uses Thereof
#1073EXPANSION OF HUMAN GROUP 2 INNATE LYMPHOID CELLS AND METHODS OF USE THEREOF
#1074COMPOSITION AND METHOD OF USE RECOMBINANT FUSION PROTEIN TO GENERATE CAR-IMMUNE CELLS
#1075BINDING DOMAINS AND METHODS OF USE THEREOF
#1076PIEZOELECTRIC SHEAR-THINNING MATERIAL COMPOSITIONS AND METHODS FOR USE
#1077SCINTILLATOR NANOCRYSTAL-CONTAINING COMPOSITIONS AND METHODS FOR THEIR USE
#1078DELIVERY AND FORMULATION OF ENGINEERED NUCLEIC ACIDS
#1079 ✅ Patent 12,364,763 granted on 2025-07-22DELIVERY AND FORMULATION OF ENGINEERED NUCLEIC ACIDS
#1080GLYCOL COMPOSITIONS INCLUDING TOCOPHEROLS
#1081PHARMACEUTICAL SYRUP FORMULATION OR SUSPENSION
#1082DRUG DELIVERY SYSTEMS COMPRISING A NEUROTROPHIC AGENT, AN APOPTOSIS SIGNALING FRAGMENT INHIBITOR (FAS) OR FAS LIGAND (FASL) INHIBITOR, A TUMOR NECROSIS FACTOR-ALPHA (TNF-ALPHA) OR TNF RECEPTOR INHIBITOR, A MITOCHONDRIAL PEPTIDE, AN OLIGONUCLEOTIDE, A CHEMOKINE INHIBITOR, OR A CYSTEINE-ASPARTIC PROTEASE INHIBITOR
#1083CNP PRODRUGS
#1084CHEMOSELECTIVE THIOL-CONJUGATION WITH ALKENE OR ALKYNE-PHOSPHONAMIDATES
#1085CONJUGATE FOR TARGETING CENTRAL NERVOUS SYSTEM
#1086CARRIER MATERIAL FOR NONTOXIC POLYCATIONIC POLYMER
#1087POLYPEPTIDE CONJUGATES FOR INTRACELLULAR DELIVERY OF NUCLEIC ACIDS
#1088ANTI-FOLATE RECEPTOR ALPHA ANTIBODY CONJUGATES AND THEIR USES
#1089ANTI-CDH6 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES THEREOF
#1090B-LYMPHOCYTE SPECIFIC AMATOXIN ANTIBODY CONJUGATES
#1091ANTIBODY-CONJUGATES FOR TARGETING OF TUMOURS EXPRESSING TROP-2
#1092GPC3 BINDING AGENTS, CONJUGATES THEREOF AND METHODS OF USING THE SAME
#1093NEODEGRADER CONJUGATES
#1094ANTI-MESOTHELIN ANTIBODY AND ANTIBODY DRUG CONJUGATE THEREOF
#1095CONJUGATE TARGETING CARDIOVASCULAR DISEASE
#1096POLYNUCLEOTIDES ENCODING GLUCOSE-6-PHOSPHATASE FOR THE TREATMENT OF GLYCOGEN STORAGE DISEASE TYPE 1A (GSD1A)
#1097Cationic Hyperbranched Starch-based Gene Carrier, Preparation Method and Application Thereof
#1098Precise Excisions of Portions of Exon 44, 50, and 53 for Treatment of Duchenne Muscular Dystrophy
#1099MITOCHONDRIAL BASE EDITORS AND METHODS FOR EDITING MITOCHONDRIAL DNA
#1100ENGINEERED MUSCLE TARGETING COMPOSITIONS
#1101EXPRESSION CASSETTES FOR TREATING EPILEPSY AND NEUROPATHIC PAIN
#1102METHODS AND SYSTEMS FOR CORRECTING MUTATIONS IN PRPH2
#1103ADENO-ASSOCIATED VIRUS COMPOSITIONS FOR RESTORING PAH GENE FUNCTION AND METHODS OF USE THEREOF
#1104 ✅ Patent 12,357,708 granted on 2025-07-15MODIFIED NUCLEOSIDES, NUCLEOTIDES, AND NUCLEIC ACIDS, AND USES THEREOF
#1105BIOCOMPATIBLE COMPOSITION FOR LABELING TARGET LESION, AND PREPARATION METHOD THEREFOR
#1106METHODS AND SYSTEMS FOR PRODUCING, USING, AND ADMINISTERING HYPERPOLARIZED FLUIDS
#1107IMMUNOSTIMULANT-CYTOTOXIC CONJUGATE COMPOSITION AND METHODS FOR CANCER TREATMENT
#1108MACROCYCLIC LIGANDS WITH PENDANT CHELATING MOIETIES AND COMPLEXES THEREOF
#1109ZWITTERIONIC METAL CHELATORS
#1110SMALL MOLECULE INHIBITORS FOR EARLY DIAGNOSIS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN CANCERS AND NEURODEGENERATIVE DISEASES
#1111FAP TARGETING CYCLIC PEPTIDES AND CONJUGATES THEREOF
#1112HUMANIZED ANTIBODY THAT BINDS TO HEG1 PROTEIN AND COMPLEX OF ANTIBODY AND RADIONUCLIDE
#1113APPARATUSES AND METHODS TO ATTENUATE VIRUSES
#1114GASPER KNOB SANITIZATION
#1115LIGHTING DEVICE
#1116MOBILE DEVICE DISINFECTION
#1117STERILIZATION METHOD AND STERILIZATION DEVICE
#1118DISINFECTION ROBOT, SYSTEM FOR DISINFECTION, AND METHOD OF DISINFECTION
#1119ROBOTIC AND AI-AUGMENTED IN SITU DETECTION AND DISINFECTION PLATFORM
#1120Automated Robotic System And Method For Sanitization And Disinfection
#1121SANITATION METHOD AND SYSTEM
#1122Enhanced Dispenser Control
#1123Scent Window Sniffer Card
#1124DIFFUSER
#1125CONTINUOUS DISINFECTION DEVICE
#1126PLASMA AIR PURIFYING APPARATUS
#1127AIR MOVING SANITATION DEVICE
#1128Thimble Bank
#1129THERAPEUTIC USE OF FIBROBLASTS FOR ADHESIVE BANDAGE WOUND HEALING
#1130STABLE COMPOSITIONS COMPOSED OF A RADIOPAQUE AGENT AND CYANOACRYLATE MONOMER AND APPLICATIONS THEREOF
#1131BIOMATERIALS FOR EMBOLIZATION AND DRUG DELIVERY
#1132TUBULAR SCAFFOLD AND METHOD OF MANUFACTURING THE SAME
#1133Charged Citrate-Based Biomaterials
#1134COMPOSITION OF SUBSTANTIALLY SPHERICAL GRANULE FOR BONE REGENERATION
#1135TISSUE GRAFT AND PROCESSING METHODS
#1136SOFT TISSUE PROTEIN COMPOSITIONS, METHODS OF MAKING, AND USES THEREOF
#1137MATERIALS WITH IMPROVED PROPERTIES
#1138METHOD OF TREATING SPINAL DISK
#1139INTEGRATED BIOMATERIAL SCAFFOLD WITH 3D PRINTED LATTICE BACKBONE
#1140SILICONE MATERIAL FUNCTIONALIZED WITH COPPER NANOPARTICLES WHICH REDUCES BACTERIAL LOAD AND BIOFILM FORMATION
#1141Methods and Products to Detect, Minimize and Treat TRAP-Related Tissue Reactions and Tissue Injury Associated With Medical Devices
#1142FLEXICOAT BLOOD-INTERFACE MATERIALS FOR BIO-COMPATABLE IMPLANTS AND DEVICES
#1143BIODEGRADABLE IRON-CONTAINING COMPOSITIONS, METHODS OF PREPARING AND APPLICATIONS THEREFOR
#1144Breast Pumping System
#1145BREAST PUMP DEVICE
#1146OPEN-CLOSED LOOP PERFUSION RESERVOIR
#1147SYSTEM AND METHOD FOR MAINTAINING WORKING PHYSIOLOGICAL RESIN BEAD GEL COMPOSITION WITHIN AN ARTIFICIAL KIDNEY
#1148Transfer Set with Integral Access Port
#1149APPROACHES TO MITIGATING PRESSURE APPLIED TO IMMOBILIZED PATIENTS UNDERGOING TREATMENT BY UNDERLYING SURFACES AND ASSOCIATED SYSTEMS
#1150APPROACHES TO MITIGATING PRESSURE APPLIED TO IMMOBILIZED PATIENTS UNDERGOING TREATMENT BY UNDERLYING SURFACES AND ASSOCIATED SYSTEMS
#1151PRESSURE-MITIGATION APPARATUSES FOR IMPROVED TREATMENT OF IMMOBILIZED PATIENTS AND ASSOCIATED SYSTEMS AND METHODS
#1152Portable Device With Disposable Reservoir For Collection Of Internal Fluid After Surgery From A Plurality Of Sites Simultaneously
#1153SYSTEMS AND METHODS FOR DETECTING NEGATIVE PRESSURE WOUND THERAPY DRESSING LEAKAGE USING STETHOSCOPE
#1154ENDOLUMINAL TREATMENT DEVICES AND RELATED METHODS
#1155CANISTER CONNECTION SYSTEM FOR DISPOSABLE NEGATIVE PRESSURE WOUND THERAPY SYSTEM
#1156ENERGY DELIVERY DEVICE AND METHODS OF USE
#1157DRUG SOLUTION INJECTION DEVICE
#1158Smart Wearable Injection and/or Infusion Device
#1159Apparatus of Cerebrospinal Fluid Pump
#1160FLUID DELIVERY SYSTEMS AND METHODS FOR CONTINUOUS FLUID FLOW
#1161MEDICAL FLUID CONTROL DEVICE
#1162SYSTEMS, APPARATUSES AND METHODS FOR OCCLUSION DETECTION USING PUMP OPERATION MEASUREMENT
#1163ELECTRONIC DEVICE FOR COLLECTING DRUG INJECTION INFORMATION ACCORDING TO USE OF PATIENT-CONTROLLED ANALGESIA (PCA) DEVICE, CONTROL METHOD THEREFOR, AND SYSTEM
#1164CLOSED LOOP INFUSION PUMP CONTROL
#1165TREND BASED ADJUSTMENTS TO INSULIN DOSAGE
#1166METHOD TO AVOID HYPOGLYCEMIA BY MINIMIZING LATE POST-PRANDIAL INSULIN INFUSION IN AID SYSTEM
#1167DOSING OF INCRETIN PATHWAY DRUGS
#1168Switching Between Medicament Delivery Control Algorithms
#1169CARTRIDGE ASSEMBLY AND METHOD FOR ASSEMBLING THE SAME
#1170A BOTULINUM TOXIN SYRINGE
#1171Gliding Performances Improved Through Trim Rib Dimensional Geometry/Shape
#1172END OF DOSE INDICATORS
#1173EXCESS DOSE ALERT SYSTEM FOR A DOSING PEN
#1174ELECTRONIC ENCODER MODULE FOR A DRUG DELIVERY DEVICE AND DRUG DELIVERY DEVICE
#1175PRECISION SYRINGE ACTUATOR SYSTEM
#1176DETACHABLE NEEDLE PROTECTION CAP FOR INJECTION DEVICES
#1177AUTOINJECTOR WITH ANTI-ACTIVATION FEATURE
#1178SAFETY DEVICE FOR A NEEDLE AND SAFETY NEEDLE SYSTEM COMPRISING A SAFETY DEVICE
#1179Safety Device for a Syringe
#1180PUNCTURE DEVICE AND MEDICINAL SOLUTION ADMINISTERING DEVICE EQUIPPED WITH PUNCTURE DEVICE
#1181CLAMPING DEVICE FOR STEADY NEEDLE INJECTING
#1182NOZZLE
#1183ELECTRONIC DEVICES AND LIQUIDS FOR AEROSOLIZING AND INHALING THEREWITH
#1184A METHOD AND AN INSUFFLATOR FOR DETERMINING A VALUE OF A VOLUME OF INSUFFLATING GAS TO BE DRAWN FROM AN INSUFFLATED CAVITY DURING EVACUATING OF THE CAVITY
#1185REPLACEABLE FLOW TRACT FOR AN INHALER
#1186DRY POWDER INHALER AND SYSTEM FOR DRUG DELIVERY
#1187AEROSOL-GENERATING SYSTEM WITH FLUID SENSOR
#1188COMPACT INHALER MECHANISM
#1189TREATMENT OF PULMONARY CANCERS USING AN ELECTRONIC BREATH ACTUATED DROPLET DELIVERY DEVICE
#1190Nasal Administration
#1191ASSEMBLY FOR CONTROLLING THE NASAL DELIVERY OF A PRODUCT, AND ASSOCIATED DELIVERY SYSTEM AND CONTROL METHOD
#1192ENDOTRACHEAL TUBE WITH PRESSURE SENSOR AND A METHOD OF MANUFACTURE THEREOF
#1193DIFFERENTIAL PRESSURE FLOW METER
#1194Nasal Cannula Assembly
#1195Electronic Nasal Cannula Flame Detector And Oxygen Shutoff Device
#1196MAGNETIC CONNECTOR
#1197CONNECTORS FOR RESPIRATORY ASSISTANCE SYSTEMS
#1198SYSTEMS AND METHODS FOR GENERATING CONCENTRATED OXYGEN
#1199BREATHING TUBE WITH A MORE EASILY INTERCHANGEABLE BREATHING-GAS FILTER
#1200HUMIDIFIER RESERVOIR